Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Non-Current Assets Payables Pension Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Intelligent Bio Solutions (INBS) Other Non-Current Liabilities (2023)

Intelligent Bio Solutions has reported Other Non-Current Liabilities over the past 1 years, most recently at $8714.0 for Q2 2023.

For Q2 2023, Other Non-Current Liabilities changed N/A year-over-year to $8714.0; the TTM value through Jun 2023 reached $8714.0, changed N/A, while the annual FY2023 figure was $8714.0, N/A changed from the prior year.
Other Non-Current Liabilities for Q2 2023 was $8714.0 at Intelligent Bio Solutions.
Over five years, Other Non-Current Liabilities peaked at $8714.0 in Q2 2023 and troughed at $8714.0 in Q2 2023.